Factors associated with HbA1c and weight changes at 6 months in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audit

C. Walton¹, R.E.J. Ryder², M.L. Cull², A.P. Mills², K.Y.Thong²

¹Diabetes, Hull Royal Infirmary, Hull UK

²Diabetes, City Hospital, Birmingham, UK

The Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits

R.E.J. Ryder¹, K.Y. Thong¹, M.L. Cull¹, A.P. Mills¹, C. Walton², ABCD nationwide exenatide and liraglutide audit contributors;

¹Diabetes, Endocrinology and Lipids Metabolism, City Hospital, Birmingham, UK

²Hull Royal Infirmary, Hull,UK

Response of HbA1c and weight against time in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits

Ken Y Thong¹, Bob Ryder¹ on behalf of the ABCD nationwide exenatide and liraglutide audits contributors

¹City Hospital, Birmingham, UK

16.6% (1 in 6) patients who continued insulin at the time of exenatide start came off insulin in the Association of British Clinical Diabetologists (ABCD) Nationwide Exenatide Audit

K.Y. Thong¹, B. Jose¹, N. Sukumar¹, M.L. Cull¹, A.P. Mills¹, T. Sathyapalan², W. Shafiq², A. Rigby², C. Walton², R.E.J. Ryder¹, on behalf of the ABCD nationwide exenatide audit contributors;

¹Diabetes, City Hospital, Birmingham, United Kingdom

Response at 3 months to insulin dose decisions made at exenatide initiation in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit

K.Y. Thong¹, R.E.J. Ryder¹, B. Jose¹, T. Sathyapalan², W. Sha!q² , A. Rigby² , C. Walton² , ABCD Nationwide Exenatide Audit Contributors 

¹City Hospital, Birmingham

²Hull Royal In!rmary, United Kingdom.

Factors accounting for variability in weight and HbA1c response to exenatide in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit

R.E.J. Ryder¹, C. Walton², P.H. Winocour³ on behalf of the ABCD nationwide exenatide audit contributors

¹City Hospital, Birmingham, United Kingdom

²Hull Royal Infirmary, Hull, United Kingdom

³Queen Elizabeth II Hospital, Welwyn Garden City, United Kingdom.

Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit

R.E.J. Ryder¹, C. Walton², P.H. Winocour³, ABCD nationwide exenatide audit contributors.

¹City Hospital, Birmingham, UK

²Hull Royal Infirmary, Hull, UK

³Queen Elizabeth II Hospital, Wellwyn Garden City, UK

Differences in response between exenatide and liraglutide in the Association of British Clinical Diabetologists (ABCD) nationwide audits

R.E.J. Ryder¹ , K.Y. Thong¹ , M.L. Cull¹ , A.P. Mills¹ , C. Walton² on behalf of ABCD nationwide exenatide and liraglutide audits contributors

¹City Hospital, Diabetes, Birmingham, UK,

²Hull Royal Infirmary, Diabetes, Hull, UK